Role of transforming growth factor-β1 and -β2 in ddY mouse nephropathy

Journal of International Medical Research

Volumn 25, Issue 3, 1997, Pages 141-154

  Ye, X F ^a   Yorioka, N ^a   Oda, H ^a   Taniguchi, Y ^a   Yamakido, M ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

ddY mice; IgA nephropathy; Mesangial matrix expansion; Transforming growth factor 1; Transforming growth factor 2

Indexed keywords

CD68 ANTIGEN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GLOMERULUS; KIDNEY DISEASE; MACROPHAGE; MESANGIUM; MONOCYTE; MOUSE; NONHUMAN;

EID: 0031004507     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059702500304     Document Type: Article

References (36)

1. Imai H, Nakamoto Y, Asakura K, et al: Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 1985; 27: 756-761.
2. Galla JH: IgA nephropathy. Kidney Int 1995; 47: 377-387.
3. Sharma K, Ziyadeh FN: The transforming growth factor-β system and the kidney. Semin Nephrol 1993; 13: 116-128.
4. Sporn MB, Roberts AB, Wakefield LM, et al: Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987; 105: 1039-1045.
5. 2 in rat glomeruli. Kidney Int 1990; 38: 1095-1100.
6. Okada H, Strutz F, Danoff TM, et al: Possible pathogenesis of renal fibrosis. Kidney Int 1996; 49: S-37-S-38.
7. Wardle N: Glomerulosclerosis: the final pathway is clarified, but can we deal with the triggers? Nephron 1996; 73: 1-7.
8. Lianos EA, Orphanos V, Cattell V, et al: Glomerular expression and cell origin of transforming growth factor-beta 1 in anti-glomerular basement membrane diseases. Am J Med Sci 1994; 307: 1-5.
9. 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 1994; 45: 525-536.
10. Niemir ZI, Stein H, Noronha IL, et al: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 1995; 48: 1530-1541.
11. Bertoluci MC, Schmid H, Lachat JJ, et al: Transforming growth factor-beta in the development of rat diabetic nephropathy. Nephron 1996; 74: 189-196.
12. Sassy-Prigent C, Heudes D, Jouquey S, et al: Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Lab Invest 1995; 73: 64-71.
13. 1 during diabetic renal hypertrophy. Kidney Int 1994; 46: 430-442.
14. 1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction. Clin Exp Immunol 1994; 97: 309-314.
15. Bost KL, Bieligk SC, Jaffe BM: Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. J Immunol 1995; 154: 718-729.
16. Roelen BAJ, Lin HY, Knezevic V, et al: Expression of TGF-βs and their receptors during implantation and organogenesis of the mouse embryo. Dev Biol 1994; 166: 716-728.
17. Okuda S, Languino LR, Ruoslahti E, et al: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 1990; 86: 453-462.
18. 1 integrins and transforming growth factor-β induced matrix proteins in glomerulonephritis. Lab Invest 1993; 69: 68-76.
19. 1 underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916-927.
20. Kulozik M, Hogg A, Lankat-Buttgereit B, et al: Co-localization of transforming growth factor beta 2 with alpha1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 1990; 86: 917-922.
21. 3 during excisional wound repair. Am J Pathol 1993; 143: 368-380.
22. Ignotz RA, Massague J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-4345.
23. Nakamura T, Miller D, Ruoslahti E, et al: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 1992; 41: 1213-1221.
24. Border WA, Okuda S, Languino LR, et al: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 1990; 37: 689-695.
25. Laiho M, Saksela O, Andreasen PA, et al: Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 1986; 103: 2403-2410.
26. Laiho M, Saksela O, Keski-Oja J: Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem 1987; 262: 17467-17474.
27. Tomooka S, Border WA, Marshall BC, et al: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 1992; 42: 1462-1469.
28. Edwards DR, Murphy G, Reynolds JJ, et al: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6: 1899-1904.
29. 3 genes during mouse embryogenesis. Development 1991; 111: 117-130.
30. Horikoshi S, McCune BK, Ray PE, et al: Water deprivation stimulates transforming growth factor-β2 accumulation in the juxtaglomerular apparatus of mouse kidney. j Clin Invest 1991; 88: 2117-2122.
31. Frank S, Madiener M, Werner S: Transforming growth factors β1, β2, and β3 and their receptor are differentially regulated during normal and impaired wound healing. J Biol Chem 1996; 271: 10188-10193.
32. Sasaki H, Pollard RB, Schmitt D, et al: Transforming growth factor-β in the regulation of the immune response. Clin Immunol Immunopathol 1992; 65: 1-9.
33. 1, is the pre-dominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J Immunol 1996; 156: 2964-2971.
34. Tsunawaki S, Sporn M, Ding A, et al: Deactivation of macrophages by transforming growth factor-β. Nature 1988; 334: 260-262.
35. Goyal VK, Chatterjee PC: Changes with age in mouse kidney. Exp Geront 1980; 15: 151-160.
36. Yumura W, Sugino N, Nagasawa R, et al: Age-associated changes in renal glomeruli of mice. Exp Gerontol 1989; 24: 237-249.